Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    BOLT Gross Margin

    As of 2025-07-14, the Gross Margin of Bolt Biotherapeutics Inc (BOLT) is 7775.2%.

    Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

    BOLT Gross Margin - Historical Value
    DateValue
    2024-12-31 7775.2%
    2023-12-31 -
    2022-12-31 -
    2021-12-31 -
    2020-12-31 -
    2019-12-31 -
    2018-12-31 -
    -
    -
    -
    BOLT Gross Margin - Peers Comparison
    TickerNameValue
    950160.KQKolon TissueGene Inc11.7%
    950200.KQPsomagen Inc23.1%
    950220.KQNeoimmunetech Inc7775.2%
    ABBVAbbvie Inc70%
    AJIAAjia Innogroup Holdings Ltd38.4%
    AMGNAmgen Inc68.7%
    ARMCUn Monde International Ltd9.4%
    BIELBioElectronics Corp49.4%
    CATV4Cable TV International Inc27.2%
    CNTR.CNCentr Brands Corp-56.2%
    CPSNCapstone Systems Inc16.1%
    CXXI.CNC21 Investments Inc39.8%
    ECRPChee Corp90%
    GFP.VGreenFirst Forest Products Inc-
    GILDGilead Sciences Inc78.3%
    GRAM.U.NETPCO Holding Corp11.7%
    HOLL.CNHollister Biosciences Inc1023.6%
    HP.CNHello Pal International Inc10.5%
    INNO.CNInnocan Pharma Corp89%
    MRNAModerna Inc70.1%
    NEOVNeoVolta Inc19.3%
    NMTTNimtech Corp7775.2%
    NUNZNunzia Pharmaceutical Corp100%
    OPTIOptec International Inc35.9%
    REGNRegeneron Pharmaceuticals Inc87%
    RTSLRapid Therapeutic Science Laboratories Inc62.3%
    SIGLSignal Advance Inc100%
    SIGYSigyn Therapeutics Inc75.2%
    SLBGSlinger Bag Inc28.9%
    TRTKTORtec Group Corp73.3%
    TSOITherapeutic Solutions International Inc62.9%
    VIHDVISION HYDROGEN Corp26.7%
    VRTXVertex Pharmaceuticals Inc86.1%
    Tickers added to watchlist